Eastern Connecticut Hematology and Oncology Associates
330 Washington St #220
Norwich, Connecticut 06360
(860) 886-8362 http://www.echoassociates.org

Use our guide to learn which trials are right for you!

In 1985 Dr. Dennis Slater moved from Memorial Sloan-Kettering Cancer in New York, to Norwich, Connecticut, in response to recruitment from The William W. Backus Hospital for a medical oncologist. He began a private practice with the goal of developing a program that would allow patients to receive state of the art cancer care within their own community. 



Two years later Dr. Kandhasamy Jagathambal from Long Island Jewish Hospital in New York, joined Dr. Slater and together, they established the Norwich Cancer Center. Shortly thereafter Dr. Mandeep Dhami from the University of Connecticut came on board adding his expertise in thrombosis, hemostasis, and hematology. At that time ECHO Associates (Eastern Connecticut Hematology/Oncology) was born. As the number of patients and services increased, Dr. Dinesh Kapur from St. Francis Hospital in Hartford joined ECHO. He also serves as Clinical Director for Cancer Services at Backus Hospital. Dr. Anca Bulgaru completed a fellowship in Hematology/Oncology at Montefiore Hospital in New York and joined the practice in 2003. In 2008 having completed a fellowship at the John Hopkins Hospital in Baltimore, Dr. Jie Yang, teamed up with ECHO. Dr. Renuka Dulala, our newest associate, completed a fellowship at Long Island Jewish Hospital in NY and came on board in 2009. 



Presently seven board certified physicians, two board certified nurse practitioners, one physician assistant, nine registered nurses, 3 licensed practical nurses and a support staff of over 60 employees make up a team to provide our patients with a wide range of medical and support services.



Research plays an important role in our practice. We participate in many pharmaceutical trials including ECOG, NSABP, NCI and Pharmaceutical sponsored studies. You and your doctor can decide if a clinical trial would be right for you.



We are proud of our relationship with The ECHO Cancer Foundation, a private not-for-profit organization whose mission is dedicated to providing supportive services, guidance and education to cancer patients and their caregivers.



Our expanded offices and services are located in the Medical Office Building of Backus Hospital (just upstairs from Radiation Therapy and close to the Cancer Inpatient Unit at Backus). We believe our goal of providing comprehensive, state of the art community cancer care has been met. We will always strive to remain responsive to our patients, their families, and our community.

We've found
13 trials
at this facility
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects
Status: Enrolling
Updated: 9/21/2017
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
Status: Enrolling
Updated: 2/2/2018
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Norwich, CT
Click here to add this to my saved trials